Ask AI

Interactive Tools and Resources for the Current Management of mCRPC: Focus on Radioligand Therapies

Gain expert insights into current and emerging clinical data on radioligand therapies used to manage metastatic castration-resistant prostate cancer (mCRPC) and the role of PSMA PET/CT to predict response through an Interactive Decision Support Tool, certified Clinical Focus text module, and accompanying downloadable slides.

Share

Program Content

No activities added yet

No activities added yet

No activities added yet

Provided by

ProCE Banner

Provided by Clinical Care Options, LLC.

Supporters

Supported by an educational grant from Novartis Pharmaceuticals Corporation.

Novartis Pharmaceuticals Corporation